1 | Study | 2.08% | |
2 | Patients | 0.82% | |
3 | Cancer | 0.77% | |
4 | Health | 0.77% | |
5 | Disease | 0.77% | |
6 | Risk | 0.77% | |
7 | New | 0.77% | |
8 | Case | 0.68% | |
9 | Report | 0.59% | |
10 | Finds | 0.54% | |
11 | Treatment | 0.5% | |
12 | mRNA | 0.5% | |
13 | May | 0.5% | |
14 | AI | 0.41% | |
15 | HIV | 0.41% | |
16 | Drug | 0.41% | |
17 | Therapy | 0.41% | |
18 | Diabetes | 0.36% | |
19 | Researchers | 0.36% | |
20 | Alzheimer’s | 0.36% | |
21 | Patient | 0.36% | |
22 | Acute | 0.32% | |
23 | Gene | 0.32% | |
24 | Pain | 0.32% | |
25 | UK | 0.32% | |
26 | Adults | 0.32% | |
27 | Management | 0.32% | |
28 | Brain | 0.32% | |
29 | Life | 0.27% | |
30 | Chronic | 0.27% | |
31 | Hindustan | 0.27% | |
32 | Times | 0.27% | |
33 | Cell | 0.27% | |
34 | Between | 0.27% | |
35 | Heart | 0.27% | |
36 | Care | 0.27% | |
37 | Prostate | 0.27% | |
38 | Kidney | 0.27% | |
39 | Linked | 0.27% | |
40 | Blood | 0.27% | |
41 | Association | 0.27% | |
42 | Safety | 0.23% | |
43 | Prevalence | 0.23% | |
44 | Syndrome | 0.23% | |
45 | Breakthrough | 0.23% | |
46 | Metabolic | 0.23% | |
47 | Severe | 0.23% | |
48 | Dermatitis | 0.23% | |
49 | Clinical | 0.23% | |
50 | According | 0.23% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Larotrectinib Shows Durable Responses, Safety in TRK Fusion Thyroid Carcinoma
Targeted Oncology
2025-06-07 06:00:00